4//SEC Filing
Quimi Daphne 4
Accession 0000899243-23-015408
CIK 0001658551other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:39 PM ET
Size
9.5 KB
Accession
0000899243-23-015408
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-08+16,985→ 16,985 totalExercise: $26.25Exp: 2033-06-08→ Common Stock (16,985 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 8, 2024 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:39 PM ET
- Size
- 9.5 KB